Navigation Links
Registration Open for OpenClinica European Summit - April 14, 2009
Date:1/20/2009

Event in Brussels to bring together community around OpenClinica open source clinical trial software.

Brussels, Belgium (PRWEB) January 20, 2009 -- Akaza Research announces the first annual OpenClinica European Summit. The event will be held on April 14, 2009 in Brussels, Belgium and bring together users, developers, and leading service providers of the OpenClinica open source electronic data capture (EDC) software.

The Summit is open to the public and will feature engaging presentations by clinical trial sponsors, contract research organizations, academic and government research institutions, and providers of EDC-related services. Conference session formats will include case studies, panel discussions, sessions for end-users as well as system administrators and developers. The keynote presentation will be given by Akaza's CEO Cal Collins.

"This is an exciting time for OpenClinica users in Europe," said Mr. Collins. "The rapid growth in the software's popularity and use in clinical trials by European organizations should make this a very productive and informative event. I look forward to engaging with our European community about OpenClinica's developments and direction."

For more information and to register for the event, see http://www.openclinica.org/European_Summit.html.

Early bird deadline for registration is January 30, 2009.

About OpenClinica®
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world's most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1885874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
2. Anacor Files Registration Statement for Initial Public Offering
3. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
4. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
5. SyntheMed Files Universal Shelf Registration
6. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
7. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
8. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
9. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
10. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
11. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Registration Open for OpenClinica European Summit - April 14, 2009
(Date:5/19/2016)... There is no saying when ... relentless pressures in pricing and lack in consumer confidence. ... though - numerous opportunities are up for grabs but ... presents four names in this sector: Portola Pharmaceuticals Inc. ... VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
(Date:5/18/2016)... ... 2016 , ... Shimadzu Scientific Instruments announces its sponsorship of ... two-day camp will take place annually starting June 2016. It will provide qualifying ... preparation for a university academic program. , The laboratory- and technology-focused camp ...
(Date:5/18/2016)... Kansas (PRWEB) , ... May 18, 2016 , ... Ryan ... given a life expectancy in the late teens to early twenties. DMD is a ... In 2009, at the age of 22, Benton’s condition was critical. He met with ...
(Date:5/17/2016)... New York, NY (PRWEB) , ... May 17, 2016 , ... ... Awareness Month, buildings, bridges, and monuments across the globe will show their support in ... of NF. , Neurofibromatosis, NF, is a genetic disorder that causes tumors to ...
Breaking Biology Technology:
(Date:3/17/2016)... -- ABI Research, the leader in transformative technology ... will reach more than $30 billion by 2021, ... electronics, particularly smartphones, continue to boost the biometrics ... two billion shipments by 2021 at a 40% ... Analyst at ABI Research. "Surveillance is also gearing ...
(Date:3/15/2016)... , March 15, 2016 Yissum Research ... the technology-transfer company of the Hebrew University, announced today ... remote sensing technology of various human biological indicators. Neteera ... $2.0 million from private investors. ... on the detection of electromagnetic emissions from sweat ducts, ...
(Date:3/14/2016)... 2016 http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ... --> DERMALOG, le leader de ... lecteurs d,empreintes digitales pour l,enregistrement des réfugiés en ... pour produire des cartes d,identité aux réfugiés. DERMALOG ...
Breaking Biology News(10 mins):